Skip to main content
OpenTrials

Clinical trial condition

Polyneuropathies

Explore clinical trials studying Polyneuropathies. Study availability and eligibility vary by location and protocol.

430 public trials 123 recruiting studies
Refine in advanced search Browse all conditions

Polyneuropathies trial results

Recruiting

A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)

NCT06858579

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +12 more
Locations
  • Clinical Study Site Birmingham, Alabama, United States
  • Clinical Study Site Phoenix, Arizona, United States
  • Clinical Study Site Scottsdale, Arizona, United States
  • Clinical Study Site Los Angeles, California, United States
View all 180 locations
View Trial Details
Recruiting

A Study to Evaluate the Pharmacokinetics and Safety of XEMBIFY Versus Gamunex-C in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy

NCT07540221

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, CIDP (Chronic Inflammatory Demyelinating Polyradiculoneuropathy), +12 more
Locations
  • GC2402 Study Site 104 Rancho Mirage, California, United States
  • GC2402 Study Site 109 Coral Springs, Florida, United States
  • GC2402 Study Site 105 Miami, Florida, United States
  • GC2402 Study Site 103 Port Charlotte, Florida, United States
View Trial Details
Recruiting

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

NCT05768139

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +40 more
Locations
  • Ellison Clinic at Saint John's Los Angeles, California, United States
  • UCSF Medical Center at Mission Bay San Francisco, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • Yale-New Haven Hospital New Haven, Connecticut, United States
View all 65 locations
View Trial Details
Recruiting

Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

NCT05327114

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +11 more
Locations
  • IMMUNOe Health and Research Centers Centennial, Colorado, United States
  • Healthcare Innovations Institute Inc Coral Springs, Florida, United States
  • Neurology Associates PA Maitland, Florida, United States
  • ALS Center at the University of Miami Miami, Florida, United States
View all 118 locations
View Trial Details
Recruiting

Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer

NCT07558733

Conditions
Breast Diseases, Breast Neoplasms, Congenital Abnormalities, +15 more
Locations
  • START Los Angeles Los Angeles, California, United States
  • Rocky Mountain Cancer Centers Lone Tree, Colorado, United States
  • Oncology Associates of Oregon Springfield, Oregon, United States
  • SCRI Oncology Partners Nashville, Tennessee, United States
View Trial Details
Recruiting

A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% KIg10 (QIVIGY) in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

NCT06752356

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +12 more
Locations
  • USF Health - Morsani Center for Advanced Healthcare Tampa, Florida, United States
  • Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States
  • Advanced Neurology Epilepsy and Sleep Center/ANESC Research El Paso, Texas, United States
View Trial Details
Recruiting

A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases

NCT07304154

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +22 more
Locations
  • Stanford Neuroscience Health Center Palo Alto, California, United States
  • Columbia University Irving Medical Center New York, United States
  • LDS Hospital - Intermountain Health Salt Lake City, Utah, United States
  • Fred Hutchinson Cancer Center Seattle, Washington, United States
View Trial Details
Recruiting

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

NCT06993844

Conditions
Adnexal Diseases, Advanced Breast Cancer, Advanced Solid Tumors, +40 more
Locations
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Yale University, Yale Cancer Center New Haven, Connecticut, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View all 15 locations
View Trial Details

Related conditions